Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00426595Phase 2Completed
A Phase 2 trial of omeprazole in gastroesophageal reflux disease (GERD), reflux esophagitis, sponsored by Ghent University Hospital. Started Apr 2007; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00426595.